Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Koele SE, van Beek SW, van der Wekken AJ, Piet B, van den Heuvel MM, Ter Heine R. Pharmacokinetically-guided dosing to improve the efficacy of brigatinib in non-small cell lung cancer patients. Br J Clin Pharmacol 2021;88:1930-1934. [PMID: 34545619 PMCID: PMC9292371 DOI: 10.1111/bcp.15088] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2021] [Revised: 09/08/2021] [Accepted: 09/12/2021] [Indexed: 01/25/2023] Open

For:	Koele SE, van Beek SW, van der Wekken AJ, Piet B, van den Heuvel MM, Ter Heine R. Pharmacokinetically-guided dosing to improve the efficacy of brigatinib in non-small cell lung cancer patients. Br J Clin Pharmacol 2021;88:1930-1934. [PMID: 34545619 PMCID: PMC9292371 DOI: 10.1111/bcp.15088] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2021] [Revised: 09/08/2021] [Accepted: 09/12/2021] [Indexed: 01/25/2023] Open

Number

Cited by Other Article(s)

Gupta N, Hanley MJ, Sinha V. Pharmacometric analyses and clinical evidence for brigatinib dosing in anaplastic lymphoma kinase-positive non-small cell lung cancer. Br J Clin Pharmacol 2022;88:3922-3923. [PMID: 35350085 DOI: 10.1111/bcp.15322] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2022] [Accepted: 02/28/2022] [Indexed: 01/26/2023] Open